Algorithm for iron therapy in management of anemia of CKD

Slides:



Advertisements
Similar presentations
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 3: Clinical Indicators and Preventive Care.
Advertisements

Figure 3.1 ESRD clinical indicators, CROWNWeb data, December 2015
The adrenal cortex consists of three histologically distinct zones: the outer zona glomerulosa, the middle zona fasciculata, and an innermost layer called.
Source: Saseen JJ, MacLaughlin EJ. Hypertension
Life cycle of microsporidia
From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):
Acute irritant contact dermatitis on the hand due to an industrial solvent. There is massive blistering on the palm. (From Wolff K, Johnson RA. Eczema/dermatitis.
The predominant types of vascular access for chronic dialysis patients are (A) the arteriovenous fistula and (B) the synthetic arteriovenous forearm graft.
Algorithm for the pharmacotherapy of social anxiety disorder
Algorithm for the management of increased ICP
The myometrium is incised carefully to avoid cutting the fetal head
Algorithm for management of anemia of CKD in adults
Pathogenesis of bone diseases in chronic kidney disease
Source: Reprinted with permission from the American Association of Clinical Endocrinologists. Garber AJ, Abraham-son, MJ, Barzilay JI, et al. AACE comprehensive.
Treatment approaches for Crohn disease. (Adapted from Hemstreet BA
Treatment algorithm for hyperuricemia in gout
Kidney Disease Improving Global Outcome (KDIGO) classification of chronic kidney disease (CKD). Gradation of color from green to red corresponds to increasing.
Diagnostic algorithm for normocytic anemia.
Gompertzian kinetics tumor-growth curve: relationship to symptoms, diagnosis, and various treatment regimens. (Reproduced with permission from Buick RN.
Proper use of a metered-dose inhaler (MDI)
(Reproduced with permission from Lau TL, Kim C, Ginsberg MH, et al
Algorithm for pain management in oncology patients
Algorithm for the treatment of atrial fibrillation (AF) and atrial flutter. (BB, β-blocker; CCB, calcium channel blocker [i.e., verapamil or diltiazem];
Cancer incidences (left) and deaths (right) in the United States for males and females—2011 estimates. (Reproduced from American Cancer Society. Cancer.
Changes in the ovarian follicle, endometrial thickness, and serum hormone levels during a 28-day menstrual cycle. P, progesterone; E2, estradiol; LH, luteinizing.
Guidelines for the evaluation and management of a patient who presents with dyspeptic or ulcer-like symptoms. (COX-2, cyclooxygenase-2; GERD, gastroesophageal.
Algorithm for the metabolic management of type 2 diabetes mellitus; reinforce lifestyle interventions at every visit and check hemoglobin A1c every 3 months.
Management of an elevated INR in patients taking warfarin
Nodules are palpable, solid, round, or ellipsoidal lesions
Signs and symptoms of anorexia nervosa and bulimia nervosa
Pathogenesis of CKD-MBD and renal osteodystrophy
(Reproduced with permission from Afifi AK, Bergman RA
Normal glomerular autoregulation serves to maintain intraglomerular capillary hydrostatic pressure, glomerular filtration rate (GFR), and, ultimately,
Advanced stage non–small cell lung cancer treatment algorithm
(Adapted and reprinted with permission, from Hughes JM et al: Effect of lung volume on the distribution of pulmonary blood flow in man. Respir Physiol.
The processing of microRNA that is involved in gene regulation by RNA interference. (Reprinted with permission from Brooker RJ: Genetics: Analysis & Principles,
Adapted with permission from Hsia, J et al
Treatment algorithm for adult cardiopulmonary arrest: advanced cardiac life support (ACLS) Source: Chapter 18. Cardiac Arrest, Pharmacotherapy: A Pathophysiologic.
Recommendations for the treatment of established RA (disease duration 6 month or longer). Biologic, biological originator DMARD or boDMARD; DMARD, disease-modifying.
Sickle cell gene inheritance scheme for one parent with sickle cell trait (SCT) and one parent with no sickle cell gene. Possibilities with each pregnancy:
(Copyright © 1977 American Diabetes Association. Marliss EB et al
Diagram of the placement of a peritoneal dialysis catheter through the abdominal wall into the peritoneal cavity. (From Sowinski KM, Churchwell MD, Decker.
Copyright © 2017 McGraw-Hill Education. All rights reserved
A. Wheals are rounded or flat-topped papules or plaques that are characteristically evanescent, disappearing within hours. An eruption consisting of wheals.
Major cerebral veins and venous sinuses subject to thrombotic occlusion. (Used with permission from Waxman S. Clinical Neuroanatomy. 26th ed. New York,
Treatment algorithm for CIS and relapsing-remitting MS
Multi-color FISH study
(Used with permission from Lichtman’s Atlas of Hematology, www
[From: Galli : et al: Emergency Orthopedics: The Spine
A summary of the metabolism of glucose in: (1) the cytoplasm, and in the mitochondria by (2) pyruvate breakdown, (3) the Krebs or citric acid cycle, and.
(From Stone NJ, Robinson JG, Lichtenstein AH, et al
Algorithm for guideline-directed medical therapy for patients with SIHD. Colors correspond to the class of recommendations in the ACCF/AHATable The.
Chapter 2: Clinical Indicators and Preventive Care
A. Besarab  Kidney International  Volume 69, Pages S13-S18 (May 2006)
New options for the anemia of chronic kidney disease
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations.
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A
Volume 2: End-Stage Renal Disease
Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target  Szu-Chun Hung, Der-Cherng Tarng  Kidney International 
Chapter 2: Use of iron to treat anemia in CKD
Volume 70, Pages S21-S25 (December 2006)
Chapter 4: Red cell transfusion to treat anemia in CKD
The DOPPS Practice Monitor for US Dialysis Care: Update on Trends in Anemia Management 2 Years Into the Bundle  Douglas S. Fuller, MS, Ronald L. Pisoni,
This Month in AJKD American Journal of Kidney Diseases
CPR 1.2.: Evaluation of Anemia in CKD
Francesco Locatelli, Lucia Del Vecchio  Kidney International 
Manish M. Tanna, MD, Edward F. Vonesh, PhD, Stephen M. Korbet, MD 
Volume 80, Issue 5, Pages (September 2011)
Presentation transcript:

Algorithm for iron therapy in management of anemia of CKD Algorithm for iron therapy in management of anemia of CKD. (ESA, erythropoiesis-stimulating agent; Hb, hemoglobin; HD-CKD, hemodialysis patients; ND-CKD, nondialysis CKD patients; PD-CKD, peritoneal dialysis patients; TSat, transferrin saturation.) Reprinted with permission from Wells BG, DiPiro JT, Schwinghammer TL, et al. Pharmacotherapy Handbook. 10th ed. New York, NY: McGraw-Hill; 2017. Source: Chronic Kidney Disease (CKD), Quick Answers: Pharmacy Citation: Roller LK, Baumgartner L, Desselle SP. Quick Answers: Pharmacy; 2017 Available at: https://accesspharmacy.mhmedical.com/DownloadImage.aspx?image=/data/books/2222/acpquick_chc6_05.png&sec=172653480&BookID=2222&ChapterSecID=172653440&imagename= Accessed: December 28, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved